AstraZeneca Reports Lynparza Success in Breast Cancer Trials

AstraZeneca Reports Lynparza Success in Breast Cancer Trials


AstraZeneca plc said Monday that one of its new drugs has proven more effective than chemotherapy in treating a certain type of breast cancer. The Anglo-Swedish firm said Lynparza showed a statistically significant and clinically meaningful improvement in progression-free survival, when compares with a physician's choice of standard chemotherapy, during its phase III OlympiAD trial.



from Biotech News